TY - JOUR
T1 - Colombian consensus for the prevention, diagnosis and treatment of thrombotic conditions in adults with COVID-19
T2 - applying GRADE Evidence to Decision (EtD) Frameworks
AU - Acevedo-Peña, Juan
AU - Yomayusa-González, Nancy
AU - Cantor-Cruz, Francy
AU - Pinzón-Flórez, Carlos
AU - Barrero-Garzón, Liliana
AU - De-La-Hoz-Siegler, Ilich
AU - Low-Padilla, Eduardo
AU - Ramírez-Cerón, Carlos
AU - Combariza-Vallejo, Felipe
AU - Arias-Barrera, Carlos
AU - Moreno-Cortés, Javier
AU - Rozo-Vanstrahlen, José
AU - Correa-Pérez, Liliana
AU - Rojas-Gambasica, José
AU - González-González, Camilo
AU - La-Rotta-Caballero, Eduardo
AU - Contreras-Páez, Rubén
AU - Lineros-Montañez, Alberto
AU - Ordoñez-Cardales, Jorge
AU - Escobar-Olaya, Mario
AU - Izaguirre-Ávila, Raúl
AU - Campos-Guerra, Joao
AU - Accini-Mendoza, José
AU - Pizarro-Gómez, Camilo
AU - Patiño-Pérez, Adulkarín
AU - Flores-Rodríguez, Janine
AU - Valencia-Moreno, Albert
AU - Londoño-Villegas, Alejandro
AU - Saavedra-Rodríguez, Alfredo
AU - Madera-Rojas, Ana
AU - Caballero-Arteagam, Andrés
AU - Díaz-Campos, Andrés
AU - Correa-Rivera, Felipe
AU - Mantilla-Reinaud, Andrés
AU - Becerra-Torres, Ángela
AU - Peña-Castellanos, Ángela
AU - Reina-Soler, Aura
AU - Escobar-Suarez, Bibiana
AU - Patiño-Escobar, Bonell
AU - Rodríguez-Cortés, Camilo
AU - Rebolledo-Maldonado, Carlos
AU - Ocampo-Botero, Carlos
AU - Rivera-Ordoñez, Carlos
AU - Saavedra-Trujillo, Carlos
AU - Figueroa-Restrepo, Catalina
AU - Agudelo-López, Claudia
AU - Jaramillo-Villegas, Claudia
AU - Villaquirán-Torres, Claudio
AU - Rodríguez-Ariza, Daniel
AU - Rincón-Valenzuela, David
AU - Lemus-Rojas, Melissa
AU - Pinto-Pinzón, Diego
AU - Garzón-Díaz, Diego
AU - Cubillos-Apolinar, Diego
AU - Beltrán-Linares, Edgar
AU - Kondo-Rodríguez, Emilio
AU - Yama-Mosquera, Erica
AU - Polania-Fierro, Ernesto
AU - Real-Urbina, Evalo
AU - Rosas-Romero, Andrés
AU - Mendoza-Beltrán, Fernán
AU - Guevara-Pulido, Fredy
AU - Celia-Márquez, Gina
AU - Ramos-Ramos, Gloria
AU - Prada-Martínez, Gonzalo
AU - León-Basantes, Guillermo
AU - Liévano-Sánchez, Guillermo
AU - Ortíz-Ruíz, Guillermo
AU - Barreto-García, Gustavo
AU - Ibagón-Nieto, Harold
AU - Idrobo-Quintero, Henry
AU - Martínez-Ramírez, Ingrid
AU - Solarte-Rodríguez, Ivan
AU - Quintero-Barrios, Jorge
AU - Arenas-Gamboa, Jaime
AU - Pérez-Cely, Jairo
AU - Castellanos-Parada, Jeffrey
AU - Garzón-Martínez, Fredy
AU - Luna-Ríos, Joaquín
AU - Lara-Terán, Joffre
AU - Vargas-Rodríguez, Johanna
AU - Dueñas-Villamil, Rubén
AU - Bohórquez-Reyes, Vicente
AU - Martínez-Acosta, Carlos
AU - Gómez-Mesa, Esteban
AU - Gaitán-Rozo, Julián
AU - Cortes-Colorado, Julián
AU - Coral-Casas, Juliana
AU - Horlandy-Gómez, Laura
AU - Bautista-Toloza, Leonardo
AU - Palacios, Leonardo Palacios
AU - Fajardo-Latorre, Lina
AU - Pino-Villarreal, Luis
AU - Rojas-Puentes, Leonardo
AU - Rodríguez-Sánchez, Patricia
AU - Herrera-Méndez, Mauricio
AU - Orozco-Levi, Mauricio
AU - Sosa-Briceño, Mónica
AU - Moreno-Ruíz, Nelson
AU - Sáenz-Morales, Oscar
AU - Amaya-González, Pablo
AU - Ramírez-García, Sergio
AU - Nieto-Estrada, Víctor
AU - Carballo-Zárate, Virgil
AU - Abello-Polo, Virginia
AU - Ruiz Talero, Paula Andrea
N1 - Publisher Copyright:
© 2020 Sociedad Colombiana de Cardiología y Cirugía Cardiovascular
PY - 2020/9/1
Y1 - 2020/9/1
N2 - Introduction: recent studies have reported the occurrence of thrombotic phenomena or coagulopathy in patients with COVID-19. There are divergent positions regarding the prevention, diagnosis, and treatment of these phenomena, and current clinical practice is based solely on deductions by extension from retrospective studies, case series, observational studies, and international guidelines developed prior to the pandemic. Objective: to generate a group of recommendations on the prevention, diagnosis and management of thrombotic complications associated with COVID-19. Methods: a rapid guidance was carried out applying the GRADE Evidence to Decision (EtD) frameworks and an iterative participation system, with statistical and qualitative analysis. Results: 31 clinical recommendations were generated focused on: a) Coagulation tests in symptomatic adults with suspected infection or confirmed SARS CoV-2 infection; b) Thromboprophylaxis in adults diagnosed with COVID-19 (Risk scales, thromboprophylaxis for outpatient, in-hospital management, and duration of thromboprophylaxis after discharge from hospitalization), c) Diagnosis and treatment of thrombotic complications, and d) Management of people with previous indication of anticoagulant agents. Conclusions: recommendations of this consensus guide clinical decision-making regarding the prevention, diagnosis, and treatment of thrombotic phenomena in patients with COVID-19, and represent an agreement that will help decrease the dispersion in clinical practices according to the challenge imposed by the pandemic.
AB - Introduction: recent studies have reported the occurrence of thrombotic phenomena or coagulopathy in patients with COVID-19. There are divergent positions regarding the prevention, diagnosis, and treatment of these phenomena, and current clinical practice is based solely on deductions by extension from retrospective studies, case series, observational studies, and international guidelines developed prior to the pandemic. Objective: to generate a group of recommendations on the prevention, diagnosis and management of thrombotic complications associated with COVID-19. Methods: a rapid guidance was carried out applying the GRADE Evidence to Decision (EtD) frameworks and an iterative participation system, with statistical and qualitative analysis. Results: 31 clinical recommendations were generated focused on: a) Coagulation tests in symptomatic adults with suspected infection or confirmed SARS CoV-2 infection; b) Thromboprophylaxis in adults diagnosed with COVID-19 (Risk scales, thromboprophylaxis for outpatient, in-hospital management, and duration of thromboprophylaxis after discharge from hospitalization), c) Diagnosis and treatment of thrombotic complications, and d) Management of people with previous indication of anticoagulant agents. Conclusions: recommendations of this consensus guide clinical decision-making regarding the prevention, diagnosis, and treatment of thrombotic phenomena in patients with COVID-19, and represent an agreement that will help decrease the dispersion in clinical practices according to the challenge imposed by the pandemic.
KW - Anticoagulants
KW - COVID-19
KW - Consensus
KW - Embolism and thrombosis
KW - SARS CoV-2
UR - https://www.scopus.com/pages/publications/85095614178
U2 - 10.1016/j.rccar.2020.08.003
DO - 10.1016/j.rccar.2020.08.003
M3 - Article
AN - SCOPUS:85095614178
SN - 0120-5633
VL - 27
SP - 446
EP - 460
JO - Revista Colombiana de Cardiologia
JF - Revista Colombiana de Cardiologia
IS - 5
ER -